Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.South Africa-based Aspen Pharmacare is considering buying active pharmaceutical ingredients (API) manufacturing plant in Netherlands from Merck's MSD unit.
Subscribe to our email newsletter
In case reaching a final agreement, API operations are expected to remain in Oss while staff supporting the operations transfer with the business.
No specific details are finalized. The specifics will be subject to discussion and alignment with the Oss Works Council and Trade Union, according to MSD.
Aspen is owned in part by GlaxoSmithKline.